Peptides for Gut health
The peptides people most often research for gut health, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.
- Peptides listed
- 3
- With human trials
- 0
- FDA approved (any use)
- 0
- BPC-157Gastric pentadecapeptideAnimal evidence, 2 of 4World journal of gastroenterology 2017, PMID 29358856Human5Animal87Summarised4PCAC voted 8–6 for 503A (Jul 2026)For gut healthOverview
- KPVAnti-inflammatory tripeptideAnimal evidence, 2 of 4Inflammatory bowel diseases 2008, PMID 18092346Human4Animal6Summarised2PCAC voted 8–6 for 503A (Jul 2026)For gut healthOverview
- TB-500Synthetic fragment of thymosin beta-4No study with an outcome for gut healthPubMed search, 11 Oct 2026Human13Animal13Summarised0PCAC voted 8–6 for 503A (Jul 2026)Overview
What this list does not show
Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.
Search interest is not evidence
This list follows what people search for and discuss. It says nothing about how well any peptide works.Animal results may not carry over
Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.Approval covers specific uses
An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.Combinations are a separate question
Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.What the digestive system covers
MedlinePlus describes the digestive system as a series of hollow organs joined in a long, twisting tube that runs from the mouth to the anus and includes the esophagus, stomach and intestines.[12]
It lists signs that mean you should see a doctor, including blood in the stool, changes in bowel habits, severe abdominal pain and unintentional weight loss.[12]
The gut studies are almost all in rodents
BPC-157 has 87 animal papers and 5 human-only papers in the gut ledger, KPV has 6 animal and 4 human-only, and TB-500 has 13 of each.
Calculated from source our PubMed count ledger ledger (PubMed title/abstract counts, 2026-10-02); bpc-157 human only 5, animal only 87, rct 0; kpv human only 4, animal only 6, rct 0; tb-500 human only 13, animal only 13, rct 0. Formula: Counts copied from each peptide ledger: humanOnly = human studies not also tagged animal, animalOnly = animal studies not tagged human, rct = human randomised trials. They count papers mentioning the topic, not positive results.
In mice with DSS colitis, KPV brought earlier recovery and stronger weight regain.[2]
Oral KPV reduced the incidence of DSS- and TNBS-induced colitis in mice, with lower pro-inflammatory cytokine expression.[13]
In rats with cysteamine colitis, controls could not heal while BPC 157 induced healing. This is an animal finding.[14]
In a mouse colitis study, GHK-Cu alleviated weight loss, reduced colonic edema and promoted mucosal repair.[15]
In a human peptic ulcer study, ulcer healing by day 14 was seen in 89.5% of patients receiving intranasal Semax against 30.8% in the control group.[16]
The human VIP gut-related item is a single case report within a multi-part treatment plan.[17]
Common questions
What are the best peptides for gut health?
The colitis results cited for KPV, BPC-157 and GHK-Cu come from mice and rats.[2]
Is there a best peptide for gut health?
No head-to-head study is cited. The one human result cited is intranasal Semax in peptic ulcer: ulcer healing by day 14 in 89.5% against 30.8% in the control group.[16]
Explore nearby goals
Sources
- 1Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights.World journal of gastroenterology · 2017PMID 29358856Accessed 2 Oct 2026
- 2Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.Inflammatory bowel diseases · 2008PMID 18092346Accessed 2 Oct 2026
- 3PubMed search: ("TB-500"[tiab] OR TB500[tiab] OR "thymosin beta-4"[tiab] OR "thymosin beta4"[tiab] OR Tbeta4[tiab]) (1199 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 4PubMed search: ("TB-500"[tiab] OR TB500[tiab] OR "thymosin beta-4"[tiab] OR "thymosin beta4"[tiab] OR Tbeta4[tiab]) AND (humans[mh] OR patients[tiab]) (678 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: ("TB-500"[tiab] OR TB500[tiab] OR "thymosin beta-4"[tiab] OR "thymosin beta4"[tiab] OR Tbeta4[tiab]) AND (randomized[tiab] OR clinical trial[pt]) (18 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: ("TB-500"[tiab] OR TB500[tiab] OR "thymosin beta-4"[tiab] OR "thymosin beta4"[tiab] OR Tbeta4[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (16 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: ("TB-500"[tiab] OR TB500[tiab] OR "thymosin beta-4"[tiab] OR "thymosin beta4"[tiab] OR Tbeta4[tiab]) AND (wound[tiab] OR dermal[tiab] OR skin[tiab] OR hair[tiab]) (212 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: ("TB-500"[tiab] OR TB500[tiab] OR "thymosin beta-4"[tiab] OR "thymosin beta4"[tiab] OR Tbeta4[tiab]) AND (tendon[tiab] OR muscle[tiab] OR cardiac[tiab] OR myocardial[tiab] OR heart[tiab]) (246 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: "TB-500"[tiab] OR TB500[tiab] OR "Ac-LKKTETQ"[tiab] (33 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 10PubMed search: ("TB-500"[tiab] OR TB500[tiab] OR "thymosin beta-4"[tiab] OR "thymosin beta4"[tiab] OR Tbeta4[tiab] OR RGN-259[tiab] OR RGN-137[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (61 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 11PubMed search: ("RGN-259"[tiab] OR "RGN-137"[tiab] OR "thymosin beta 4"[tiab]) AND (eye[tiab] OR ophthalmic[tiab] OR neurotrophic[tiab] OR cornea*[tiab]) AND (patients[tiab] OR trial[tiab]) (15 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 12medlineplus.gov pagemedlineplus.gov · web pagemedlineplus.gov
- 13PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.Gastroenterology · 2008PMID 18061177Accessed 2 Oct 2026
- 14Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2013PMID 24304574Accessed 2 Oct 2026
- 15Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms.Frontiers in pharmacology · 2025PMID 40672369Accessed 2 Oct 2026
- 16Therapy of peptic ulcer with semax peptide.Bulletin of experimental biology and medicine · 2002PMID 12459874Accessed 2 Oct 2026
- 17Reversal of Refractory Ulcerative Colitis and Severe Chronic Fatigue Syndrome Symptoms Arising from Immune Disturbance in an HLA-DR/DQ Genetically Susceptible Individual with Multiple Biotoxin Exposures.The American journal of case reports · 2016PMID 27165859Accessed 2 Oct 2026
Found an error? Report a correction.